"10.1371_journal.pone.0074605","plos one","2013-09-16T00:00:00Z","Daniela Paulsen; Andreas Urban; Andreas Knorr; Claudia Hirth-Dietrich; Angela Siegling; Hans-Dieter Volk; Andrew A Mercer; Andreas Limmer; Beatrix Schumak; Percy Knolle; Helga Ruebsamen-Schaeff; Olaf Weber","AiCuris GmbH & Co.KG, Wuppertal, Germany; Bayer HealthCare AG, Leverkusen, Germany; Institute of Medical Immunology and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charit√© ‚Ä Medical University Berlin, Berlin, Germany; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand; Institutes of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany; Institute of Medical Microbiology, Immunology and Parasitology (IMMIP), University of Bonn, Bonn, Germany; Institute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany; University of Heidelberg, Heidelberg, Germany","Conceived and designed the experiments: DP AU AK CHD AM HDV AL PK OW. Performed the experiments: DP AU AK CHD AS AL PK OW. Analyzed the data: DP HRS AU AK CHD AS HDV AM AL PK BS OW. Contributed reagents/materials/analysis tools: AM. Wrote the paper: OW. Advised on parapoxvirus work: AM. Contributed to writing the manuscript: AM PK HDV.","DP and AU have been employees of Bayer. Helga Ruebsamen-Schaeff has been an employee of Bayer as well. All three co-authors are now employees of Aicuris. There are several patents/applications granted or pending. Specifically, OW, AS, AM and HDV are co-inventors on patent/application WO2003006654 ‚ÄúRecombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom‚Äù. OW and AS are co-inventors on patent/application WO200069455 ‚ÄúOrgan- tissues- and cell-specific immunotherapeutic for chronic viral infections, inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapoxvirus.‚Äù OW is inventor on patent/application WO 2007059821 ‚ÄúParapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer‚Äù. CHD, AK, AS and OW are co-inventors on patent/application WO 2002004019 ‚ÄúUse of strains of the parapox ovis virus against organ fibrosis‚Äù DP, HRS and OW are co-inventors on patent (patent number US 8343478 ‚ÄúParapoxviruses in combination with other antiviral agents for the treatment of viral diseases‚Äù). This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Daniela Paulsen","DP",12,TRUE,9,8,12,1,TRUE,TRUE,FALSE,0,NA,FALSE
